Filing Details

Accession Number:
0001178913-10-002258
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-08-30 08:17:36
Reporting Period:
2010-03-25
Filing Date:
2010-08-30
Accepted Time:
2010-08-30 08:17:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1451980 Biocancell Therapeutics Inc. BICL.TA Pharmaceutical Preparations (2834) 204630076
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1438715 Aviv Boim Beck Science Center, 8 Hartom St.
Jerusalem L3 97775
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Acquisiton 2008-07-31 800,463 $500,000.00 800,463 No 4 P Indirect By Tikcro Technologies Ltd.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Tikcro Technologies Ltd.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.01 Option to Purchase Common Stock Acquisiton 2010-03-25 20,000 $0.00 20,000 $0.85
Common Stock, Par Value $0.01 Warrant to Purchase Common Stock Acquisiton 2008-07-30 4,301,906 $0.00 4,301,906 $0.72
Common Stock, Par Value $0.01 Note Convertible into Common Stock Acquisiton 2008-07-30 3,464,385 $2,000,000.00 3,464,385 $0.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2020-03-25 No 4 A Direct
4,301,906 2008-07-30 2013-07-30 No 4 A Indirect
3,464,385 2008-07-30 2012-07-30 No 4 A Indirect
Footnotes
  1. The reporting person may be deemed to have a pecuniary interest in such securities pursuant to an agreement with the holder thereof, Tikcro Technologies Ltd.
  2. 10,000 options shall vest and be exercisable on each of September 25, 2010 and March 25, 2011.